NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 176 filers reported holding NEVRO CORP in Q2 2016. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,626,000 | +78.5% | 30,300 | +42.3% | 0.01% | +71.4% |
| Q4 2017 | $1,471,000 | -24.0% | 21,300 | 0.0% | 0.01% | -22.2% |
| Q3 2017 | $1,936,000 | +22.1% | 21,300 | 0.0% | 0.01% | +12.5% |
| Q2 2017 | $1,585,000 | +3.8% | 21,300 | +30.7% | 0.01% | 0.0% |
| Q1 2017 | $1,527,000 | +29.0% | 16,300 | 0.0% | 0.01% | +14.3% |
| Q4 2016 | $1,184,000 | +66.8% | 16,300 | +139.7% | 0.01% | +75.0% |
| Q3 2016 | $710,000 | +74.9% | 6,800 | +23.6% | 0.00% | +100.0% |
| Q2 2016 | $406,000 | +187.9% | 5,500 | +120.0% | 0.00% | +100.0% |
| Q1 2016 | $141,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |